|Tested species reactivity||Guinea pig, Human, Mouse, Pig|
|Published species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic phosphopeptide corresponding to residues surrounding pSer474 of human PAK4|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.01M HEPES, pH 7.5, with 0.15M NaCl, 100µg/ml BSA, 50% glycerol|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:1000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Miscellaneous PubMed (MISC)||See 1 publications below|
It is not recommended to aliquot this antibody.
This antibody is not cross-reactive with phosphorylated PAK1, PAK2 or PAK3.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
PA5-17636 was used in western blot to discuss the use of proteins and microRNA as treatments for cervical cancers
|Shu XR,Wu J,Sun H,Chi LQ,Wang JH||Diagnostic pathology (10:null)||2015|